UBS Asian Small Cap Equities, an award-winning strategy

Raymond Wong, Portfolio Manager for the award-winning UBS Asia Equity Small Cap strategy tells us 4 benefits of investing in this asset class.

30 Mar 2021

A win for UBS Asian small cap equity strategy! 

The strategy won “Best in Class” for the APAC small mid cap equity category in the Benchmark 2021 awards.

In a Q&A with Raymond, we asked him for his thoughts on the sector.

What’s the opportunity set for Asian small cap equities right now? Is this a good time to invest?

Asian small cap companies offer investors a unique opportunity set.

Small and mid cap companies in Asia can give investors exposure to long-term fundamental trends, like premiumization and innovation in these fast-growing markets.

At the same time, demographics trend younger in some of these markets and the middle-class is expanding rapidly, giving local companies both talent and a ready market for innovative services and products.

Asian small cap companies lagged in the general rally of 2020. As the economic recovery becomes more broad-based, this should benefit smaller companies which were hurt more in the downturn.

What are the advantages to investing in small companies versus large companies in Asia?

The Asian small and mid cap universe represents more than 3,000 companies, in growing and dynamic markets.

  • Higher alpha opportunity (ie. Performance over the general market). The small and mid cap companies are under researched by sell-side analysts, which provides more opportunities to outperform by exploiting knowledge inefficiencies. Smaller companies in Asian markets tend to attract scant analyst coverage, creating a less efficient market for smaller caps. Over the last 10 years, almost half of the fastest growing Asian companies had very limited or no analyst coverage at all. Not even 50% off the small/mid cap index is covered by five or more financial research analysts, a sharp contrast to the larger universe where the coverage is over 90%.

Overall, less researched stocks consistently delivered stronger performance over the last three years. For investors with local, boots-on-the-ground expertise, this can be an advantage

Stocks with fewer analysts covering them delivered stronger performance (MSCI Asia ex JP SMID) – 3 years performance (%) Based on average stock performance

Source: Factset alpha tester, Jefferies as of August 2020. Note: Based on average stock performance. Asian large caps and small caps as represented by MSCI Asia ex Japan and MSCI Asia ex Japan SMID respectively

Best equities house awards

UBS Asset Management won two Best equities house awards in 2021 from Morningstar and Fund Selector Asia.

In 2020, it also picked up a Singapore Group Award Equity from Lipper Fund Awards.

  • Higher growth given they are growing from a smaller base. The law of large numbers would imply that large companies tend to see slower growth due to their size. Through smaller companies, investors are able to invest in structural themes at an earlier stage and benefit from a longer runway of growth.
  • Diversification compared to Asian large cap funds. Most of the largest Asia ex-Japan funds focus on a much smaller number of large cap companies, with a fair amount of overlap in top-ten holdings between these funds. However smaller cap funds tend to look more dissimilar given the large and diversified universe.

Asia small and mid cap equities:
4 benefits for investors

#1 Higher alpha opportunity
#2 Higher growth
#3 Diversification
#4 Better focus

  • Better focus on promising segments of industries and markets. Large cap companies tend to be spread across different business lines, while small cap companies can be more focused on specific areas. For example, a large IT company may be involved in semiconductors, mobile phones, and other business lines while a smaller IT company may focus on manufacturing semiconductor components only.

Is ESG/Sustainability relevant or important to smaller companies?

We believe sustainability is important to smaller companies just as it is for large.

Although some Asian markets have been slower to adopt sustainability reporting standards than European and US markets, sustainability awareness is growing quickly in Asia.

Over the past few years, all major Asian stock exchanges have implemented ESG reporting as a listing requirement.

Investors are increasingly using ESG databases as a quick way to screen for better quality companies.

However these databases tend to have less coverage of small and mid cap companies (due to the same reasons as why these companies are under-researched) and small and mid cap companies may also have less resources dedicated to investor relations and ESG marketing.

This is another area where having boots-on-the-ground analysis is an advantage.

Our team enhances external ESG reporting data with our internal proprietary quality assessments of companies to ensure a better understanding of the companies we are investing in and to ensure we do not miss a good quality company that may have a weak ESG database score due to their lack of resources for investor education.

Why do you have a big underweight in Real Estate and a big overweight in Consumer sectors?

The real estate sector is one where larger companies have an advantage due to their scale, balance sheet strength and ability to get lower-cost funding. The smaller real estate companies may be riskier and thus we have generally been underweight in real estate.

We are overweight to the consumers sector as we believe we can find interesting opportunities in line with trends we are focusing on, like :

#1 Wallet share shifting toward discretionary consumption

As countries move from lower income (~USD 1,000 per capita) to middle income (~USD 5,000 per capita), consumers tend to upgrade their purchases from basic goods to higher quality and discretionary goods and services, as has been the experience in developed markets.

Markets such as India, Indonesia, and Philippines are all poised to transition to mid-income levels in the coming years. We expect that growth rates for categories such as home improvement, education, leisure & entertainment and health care services should accelerate, while growth rates for basic staples should start to plateau.

The shift in consumer habits as income grows

Source: Goldman Sachs Research, as of December 2019

#2 Premiumization

Apart from change in wallet share, we also expect changes within the same category as Asia sees a rapid increase in the number of high- and middle-income households.

Our research across industries and sectors shows that Asian consumers in higher income brackets are willing to pay a premium for better quality products and services.

In markets like China, these consumer trends are visible across segments such as beer, dairy, spirits, cosmetics, condiments, branded foods and four-wheelers.

In India, the premium home and personal care segment is growing at 2x the overall category growth rate, while the share of premium 2 wheelers is also rising.

In general, we believe that players providing premium products and services should continue to gain market share and benefit from this trend.

Could you please give an example of a small-cap stock that was unloved and misunderstood initially but have now grown to be a mid or large cap stock?

China Meidong, a company running mid- to high-end car dealer services across China, was one company to benefit from resilient demand in the luxury auto space during the pandemic.

A major success story within the Asia small and mid cap space, China Meidong is well exposed to the premiumization trend in China, i.e. growing demand for premium products, which we believe is underpinned by the growing middle class and consumers’ desire to trade up for better quality goods and services.

Another fast-growing company was China condiments supplier, Yihai, which we added several months after its IPO. At that time, the company saw low trading volume and was underappreciated as a condiments supplier to fast-growing hotpot chain Haidilao.

Then in 2018, Haidilao also launched its IPO and its expansion pipeline became clearer. The company also focuses on R&D to create new products independent of Haidilao's business and the take-home sauces/packs and instant hot pot helped the company benefit during the pandemic when people preferred to cook at home.

About Raymond Wong

Raymond Wong is a Portfolio Manager and Analyst within the Global Emerging Markets and Asia Pacific Equities team. He is a Portfolio Manager for Asian equities and the UBS Asian Smaller Companies Fund. He is based in Singapore.
As an analyst, he covers Asian small/mid-cap stocks and Japanese autos/auto-parts, energy, shipping/shipbuilding and trading companies.

Prior to joining UBS Asset Management in 2008, Raymond was an analyst / portfolio manager with Spencer House Capital Management. He started his fund management career at John Govett (renamed AIB Govett), and subsequently at various other fund management firms, where he focused on Japanese investments for long-only and absolute return/hedge funds.

Raymond has been in the Asia Pacific financial services industry since 1998, including roles as a securities regulator and as a management consultant.

Raymond Wong

Portfolio Manager Asia Equity Small Cap

More insights

Subscribe now

Perspectives matter. Tune in to our insights.


Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE(collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2021 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset